Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion type Assertion NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_head.
- NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion wasGeneratedBy ECO_0000203 NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_provenance.
- NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion wasDerivedFrom befree-20140225 NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_provenance.
- NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion SIO_000772 19920204 NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_provenance.
- NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion evidence source_evidence_literature NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_provenance.
- NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_provenance.